Mirror Aided Cross Education in Post Stroke Upper Limb Rehabilitation.
To Investigate the Potential Effectiveness of Mirror Aided Cross Education Using the Innovative 'Mirror Strengthening Device' Compared to Mirror Therapy Alone in Post Stroke Upper Limb Rehabilitation: A Pilot Randomised Feasibility Study.
1 other identifier
interventional
24
1 country
1
Brief Summary
This is a pilot randomised controlled trial investigating a combination of mirror therapy and cross-education training compared to mirror therapy alone for the rehabilitation of upper limb impairment following a stroke. A case study series will be completed in advance of the full randomised controlled trial. The outcome measure assessments will take place at the institution. All intervention therapy sessions will be completed by the participant in their own home with the first introductory session being completed with the lead researcher. The study will be conducted in conjunction with Sligo University Hospital once it has attained ethical approval through the relevant University Hospital Ethics Committee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Nov 2022
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2022
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedOctober 2, 2023
September 1, 2023
4 months
February 6, 2022
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Isokinetic Upper Limb Strength
(Biodex System 4 Pro with advantage software) IPRS Limited, Suffolk House, Bramford Road, Little Blakenham, Suffolk, IP8 4JU. A higher score indicates more strength.
4 weeks.
Secondary Outcomes (4)
Upper limb range of movement.
4 weeks.
Modified Ashworth Scale (MAS) for spasticity.
4 weeks.
Stroke Impact Scale measures Handicap.
4 weeks.
Fugl Meyer Upper Extremity Test
4 weeks.
Study Arms (2)
Mirror Therapy + Cross Education
EXPERIMENTALCross Education: Experimental participants will perform resisted task-specific upper limb exercises. During the exercises, participants will pull a resistance cord with their non-affected arm, Mirror Therapy: Participants will complete the exercises while looking at its reflection in a mirror covering their affected arm. Training duration \& frequency: 20-30 minutes, 5/week for 4 weeks = total 20 sessions.
Mirror Therapy Alone
ACTIVE COMPARATORMirror Therapy: Control participants will perform non-resisted task-specific upper limb exercises. Participants will complete the exercises while looking at its reflection in a mirror covering their affected arm. Training duration \& frequency: 20-30 minutes, 5/week for 4 weeks = total 20 sessions.
Interventions
Participants will perform resisted task-specific upper limb exercises. During the exercises, participants will pull a resistance cord with their non-affected arm, Participants will complete the exercises while looking at its reflection in a mirror covering their affected arm. The initial resistance will be chosen based on the participants initial outcome measure results. Repetitions of these exercises will be prescribed according to patient function and strength, and will be increased each week as their ability improves. Sessions will start with 20-minute durations, and should increase in length as the therapy progresses due to the increased repetitions, but are not expected to exceed 30 minutes. Training duration \& frequency: 20-30 minutes, 5/week for 4 weeks = total 20 sessions.
Participants will perform non-resisted task-specific upper limb exercises. During the exercises, participants will be watching their non affected arm reflected in a mirror covering their affected arm. Repetitions of these exercises will be prescribed according to patient function and strength, and will be increased each week as their ability improves. Sessions will start with 20-minute durations, and should increase in length as the therapy progresses due to the increased repetitions, but are not expected to exceed 30 minutes. Training duration \& frequency: 20-30 minutes, 5/week for 4 weeks = total 20 sessions.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of ischemic or hemorrhagic stroke as determined by a stroke neurologist. Stroke will be defined as an acute event of cerebrovascular origin causing focal or global neurologic dysfunction lasting more than 24 hours diagnosed by a neurologist/gerontologist, and confirmed by computed tomography or magnetic resonance imaging.
- ≥3 months post stroke; with no restrictions on how long post stroke.
- Discharged from formal physiotherapy rehabilitation services.
- Unilateral upper limb weakness with a Medical Research Council (MRC) Scale for Strength score greater than 2 (i.e., movement with influence of gravity removed) in the limb to be assessed and treated.
- Functional active range of movement and power in non-hemiparetic side.
- Ambulatory with or without use of a walking device. Must be able to transfer into the Biodex machine.
- Older than 18 yrs.
- Not involved in any other type of structured strength training for the duration of the study.
You may not qualify if:
- Diagnosis of additional neurological condition (including more than one stroke) or cardiovascular disease.
- Presence of musculoskeletal conditions affecting the bones and/or soft tissues of the upper extremity.
- Impaired cognition that would affect ability to informed consent (MMSE \<21).
- Presence of aphasia or visual impairments.
- Medications affecting tone less than 3/12 prior.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Technology, Sligolead
- Sligo General Hospitalcollaborator
Study Sites (1)
ATU Sligo
Sligo, Co Sligo, F94KR28, Ireland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claire Smyth, BSc
Institute of Technology, Sligo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Experimental participants will perform resisted task-specific upper limb exercises while in a seated position at their kitchen table. During the exercises, participants will pull a resistance cord with their non-affected arm, while looking at its reflection in a mirror covering their affected arm. Control participants will perform non-resisted task-specific upper limb exercises while in a seated position at their kitchen table. During the exercises, participants will be watching their non-affected arm reflected in a mirror covering their affected arm. The outcome assessor was blinded to treatment allocation. They evaluated participants in a separate lab and were asked not to discuss the treatment given to patients. Even if the the patient mentioned the trials they would discuss the fact that they were using Mirrors.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Supervisor & Head of Neuroplasticity Research Group (NRG)
Study Record Dates
First Submitted
February 6, 2022
First Posted
March 24, 2022
Study Start
November 1, 2022
Primary Completion
March 1, 2023
Study Completion
May 1, 2023
Last Updated
October 2, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
IPD will be held in coded unidentifiable files on the principle investigators computer which is password protected. If needed for systematic review analysis at a later date this data can be provided to other researchers without any issues involved or without patient personal information being identified. We will only provide necessary data required.